A Randomized Trial of the Efficacy and Tolerability of the COX-2 Inhibitor Rofecoxib vs Ibuprofen in Patients With Osteoarthritis

Authors:
  • BMBriggs Morrison
    Briggs Morrison
  • ALArmando Luza
    Armando Luza
  • OCOswaldo Castaneda
    Oswaldo Castaneda
  • ASAlberto Strusberg
    Alberto Strusberg
  • MNMenachem Nahir
    Menachem Nahir
  • KHKnut Bjorn Helgetveit
    Knut Bjorn Helgetveit
  • BKBarbara Kress
    Barbara Kress
  • BDBrian Daniels
    Brian Daniels
  • JBJames Bolognese
    James Bolognese
  • DKDave Krupa
    Dave Krupa
  • BSBeth Seidenberg
    Beth Seidenberg

Abstract
NONSTEROIDAL anti-inflammatory drugs (NSAIDs) are commonly used to treat the pain and inflammation caused by a variety of clinical disorders, including osteoarthritis (OA). The clinical effects of these drugs result primarily from the inhibition of the enzyme cyclooxygenase (COX), the first step in the conversion of arachidonic acid to prostaglandins.1

This publication has 20 references indexed in Scilit: